BREASTEST
LIVE

Serial Number

79394750

Owner

BCal Diagnostics Limited

Attorney

Nicholas D. Myers

Filing Date

Dec 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

BREASTEST Trademark

Serial Number: 79394750 • Registration: 7691496

BREASTEST is a trademark filed by BCal Diagnostics Limited on December 21, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BCal Diagnostics Limited (3 trademarks)

Suite 506, Level 5, 50 Clarence Street

Entity Type: 16

Trademark Details

Filing Date

December 21, 2023

Registration Date

February 18, 2025

Published for Opposition

December 31, 2024

Goods & Services

Chemical preparations for testing blood for medical purposes; diagnostic preparations for clinical, medical or veterinary laboratory use; diagnostic preparations for medical purposes; diagnostic products in the nature of medical diagnostic biomarkers for medical purposes; diagnostic substances for medical use; diagnostic testing materials in the nature of diagnostic test patch for application to the skin for determining allergies for medical use; diagnostic agents for pharmaceutical use; diagnostic reagents for medical purposes; preparations for medical diagnostic use; reagents for blood grouping for medical purposes; blood testing apparatus including test erythrocytes for blood diagnostic purposes; medical adhesive tapes; medical dressings; medical or veterinary chemical products in the nature of chemical reagents for diagnostic tests for medical use; medical or veterinary chemical products in the nature of chemical reagents for use in biological preparations for medical purposes; medical or veterinary chemical products in the nature of chemical reagents for use with biotechnology for medical purposes; medical or veterinary chemical preparations in the nature of chemical reagents for the vaccines and antibodies chemical products in the nature of chemical reagents and antibody reagents for the detection of antigens in cells and tissue for medical and veterinary purposes; medical or veterinary chemical preparations for therapeutic , sanitary pharmaceutical purposes for modulating or modifying lipids to improve disease outcomes for conditions including, dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical plasters; medical preparations for the treatment of dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical wound dressings

Medical analysis of tissues for the medical treatment of persons; blood testing services being medical analysis services for diagnostic and treatment purposes by medical laboratories; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical analysis services relating to the diagnosis and treatment of persons; medical analysis services relating to the treatment of patients; medical diagnostic testing, monitoring and reporting services; surgical diagnostic services relating to the treatment of patients for medical purposes; health screening services in the field of dyslipidemia, hypolipidemia, cardiovascular disease, kidney disease, diabetes, fatty liver disease, obesity, vascular disease, pancreatitis, hypothyroidism, stroke, metabolic diseases, blood cancers, breast cancer, lung cancer, pancreatic cancer, ovarian cancer and other solids cancers; medical screening; medical services; medical monitoring and reporting services of patients; remote monitoring of medical data for medical diagnosis and treatment

Diagnostic apparatus for carrying out diagnostic tests for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells used in medical laboratories for medical purposes; diagnostic apparatus for diagnostic and medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells; diagnostic apparatus for medical diagnostic purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and apparatus for blood analysis; blood testing apparatus for blood tests; apparatus for testing blood; medical apparatus for use in blood analysis; medical apparatus for the treatment of cancer; blood cell analyzing apparatus for medical use; blood component separation apparatus for medical use; blood sampling apparatus for medical use; blood testing apparatus; blood testing equipment, namely, hematology analyzers for medical diagnostic uses; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and electromagnetic medical diagnostic imaging apparatus for medical use; immunochemical medical diagnostic testing apparatus for use in detecting and measuring antibody levels immunoassay procedures; immunochemical medical diagnostic testing instruments for use in detecting and measuring antibody levels immunoassay procedure; electromedical diagnostic instruments, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; gamma instruments for measuring human cell attenuation for medical use, namely, gamma cameras for medical purposes; diagnostic apparatus for medical purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells, and medical apparatus for diagnostic purposes used in medical laboratories for testing blood-lipids, DNA, RNA, protein, metabolites, erythrocytes, white blood cells and medical diagnostic apparatus for use in testing blood in medical laboratories; medical apparatus for medical diagnostic testing of biological samples; medical diagnostic apparatus for testing blood-lipids, DNA, RNA, protein, metabolites erythrocytes, white blood cells, and medical diagnostic instruments for the analysis of body fluids; medical diagnostic testing apparatus for testing blood-lipids, DNA, RNA, protein, metabolites erythrocytes, white blood cells, and testing apparatus for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; testing instruments for medical diagnostic purposes, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; tools for medical diagnostics, namely, tube for collection of blood samples, hematology analyzers, metabolite analyzers, nucleic acid analyzers for medical diagnostics uses

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 18, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 2, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 2, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 19, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 2, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 2, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 19, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 4, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 19, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 19, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 19, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 20, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 20, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 20, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 20, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 20, 2024 COAR
REFUSAL PROCESSED BY IB
Sep 1, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 10, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 10, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 30, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jul 29, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 22, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 10, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 2, 2024 REPR